About Dylan Morris
Dylan Morris is a board member at Averna Therapeutics.
Form D filings also name Dylan Morris as a managing director at insight partners at Superluminal Medicines and a director at ImmuneBridge, Gameto and Unlearn.ai.
Dylan Morris first appears on SEC filings in 2022.
Experience
This experience comes from Dylan Morris's profile and from SEC filings. For roles taken from filings, the years are when the filings name Dylan Morris in the role, so the role may have started earlier or lasted longer.
PH
PhaseV Current
Board Director
2025 – Present
Averna Therapeutics Inc. Current
Board Member
2024 – Present · Watertown, MA
Develops gene insertion medicines for people with genetic diseases, cancer and autoimmune conditions.
Superluminal Medicines, Inc. Current
Managing Director at Insight Partners
2023 – Present · Boston, MA
Develops small-molecule medicines for people with obesity and cardiometabolic diseases.
PB
Profluent Bio Current
Board Director
2022 – Present
DI
DEM Biopharma, Inc. Current
Board Director
2022 – Present
IP
Insight Partners Current
Managing Director
2021 – Present
AR
ArrePath Current
Board Director
2021 – Present
ST
Switch Therapeutics Current
Board Director
2020 – Present
DT
Deciduous Therapeutics Current
Board Director
2019 – Present
ET
Exo Therapeutics Current
Board Observer
2019 – Present
DT
Dyno Therapeutics Current
Board Director
2018 – Present
PL
Plexium Current
Board Observer
2018 – Present
CR
CRV
General Partner
2017 – 2021
IE
Innovation Endeavors
Investment Team
2015 – 2017
IC
Integrated Plasmonics Corporation
Co-Founder
2011 – 2014
Key Colleagues at Startups
The people Dylan Morris works with at each company, as listed on that company's latest Form D.
Superluminal Medicines, Inc. · Form D, Sep 3, 2026
HP
Harsha Paladugu
Director
DX
Diamantis Xylas
Director
CC
Cony D'cruz
Co-Founder & CEO, director
NS
Nandita Shangari
Director
Averna Therapeutics Inc. · Form D/A, Mar 20, 2026
Thomas Barnes
CEO & Board Member
Roy Amariglio
Board Member
Nick Olsen
Board Member
SS
Stephen Squinto
Director
MS
Michal Silverberg
Director
Raju Prasad
Board Member
Tal Zaks
Executive Chairman of the Board
Henry Chen
Board Member
ImmuneBridge Inc. · Form D, Apr 2, 2025
NI
Nadiya Ishnazarova
Director
OD
Omri Amirav-Drory
Director
AJ
Alicia Jackson
Director
SJ
Stuart Jacobson
President and CEO, director
TF
Thomas Farrell
Director
Gameto, Inc. · Form D, May 29, 2024
MV
Martin Varsavsky
Executive officer and director
DP
Dusan Perovic
Director
DR
Dina Radenkovic
Chief Executive Officer and director
MS
Maryanna Saenko
Director
Unlearn.ai, Inc. · Form D, Feb 8, 2024
AS
Aaron Smith
Director
JM
John McGovern
Executive officer
ES
Eric Shiozaki
Director
AT
Ann Taylor
Director
Francisco Gimenez
Director
AG
Andrew Gill
Executive officer
CF
Charles Fisher
President and Chief Executive Officer, director
EM
Ermira Murati
Director